EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Impact of RSV Vaccination in Hemodialysis Patients: Real-World Evidence on Hospitalization Risk and the Role of Chronic Lung Disease

Francesca K Martino iD, Francesca Fioretti, Lucia Federica Stefanelli, Gianni Carraro, Miriam Capuano, Giuseppe Scaparrotta, Federico Nalesso iD

Advances in Respiratory Medicine · 02.07.2026 · 94 (4) · 45

DOI: 10.3390/arm94040045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Respiratory Medicine, online erschienen am 02.07.2026. Verfasst von Francesca K Martino und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology, Dialysis and Transplantation Unit, Department of Medicine (DIMED), University of Padova, 35128 Padua, Italy. Hauptthemen laut MEDLINE: Renal Dialysis, Respiratory Syncytial Virus Infections, Hospitalization, Respiratory Syncytial Virus Vaccines. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Padua, Università di Padova.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Respiratory syncytial virus (RSV) infection is a cause of respiratory morbidity in high-risk patients, including those with chronic lung disease (CLD) and those undergoing hemodialysis (HD). In HD patients, evidence on the clinical impact of RSV vaccination on respiratory complications remains limited. We aimed to assess the clinical impact of RSV vaccination in HD patients by comparing vaccinated and unvaccinated patients with a focus on CLD.

Methods

We retrospectively evaluated 56 adult HD patients: 28 received the RSV vaccine in autumn 2024 and 28 did not. Clinical data were collected from electronic medical records. Outcomes included influenza-like illness (ILI), pneumonia, and respiratory infection requiring hospitalization between September 2024 and September 2025.

Results

Patients had a mean age of 74.4 years and a median Charlson Comorbidity Index (CCI) of 10. The RSV-vaccinated group had a greater comorbidity burden than the unvaccinated group (CCI 11 IQR 10–12 vs. 9 IQR 8–11, p = 0.02) and a higher prevalence of CLD (46.4% vs. 25.0%, p = 0.09). During follow-up, 28 patients (50.0%) had at least one ILI episode, 23 (41.1%) developed pneumonia, and 15 (26.8%) were hospitalized for respiratory infection. The incidence of ILI was 46.4% in vaccinated patients and 53.6% in unvaccinated patients (p = 0.28), while the incidence of pneumonia was 39.3% and 42.9%, respectively (p = 0.78). Respiratory infection requiring hospitalization occurred in 14.3% of vaccinated patients and 39.3% of unvaccinated patients (p = 0.035). CLD was significantly associated with pneumonia (p = 0.001) and showed trends toward higher rates of ILI (p = 0.09) and hospitalization for respiratory infection (p = 0.1).

Conclusions

In our exploratory study, RSV vaccination in HD patients was associated with fewer hospitalizations for respiratory infection, despite greater comorbidity in vaccinated patients. CLD was associated with a higher incidence of respiratory complications, particularly pneumonia. The retrospective design and small sample size do not allow definitive conclusions; future prospective studies with an adequate sample size are needed to confirm our results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisRespiratory Syncytial Virus InfectionsHospitalizationRespiratory Syncytial Virus VaccinesLung DiseasesHumansFemaleRetrospective StudiesAgedMaleVaccination

Stichwörter der Autor:innen

chronic lung diseasehemodialysisrespiratory syncytial virus vaccine

Substanzen

Respiratory Syncytial Virus Vaccines

Autor:innen und Institutionen

  • Nephrology, Dialysis and Transplantation Unit, Department of Medicine (DIMED), University of Padova, 35128 Padua, Italy.

ORCID-Profile: Francesca K Martino, Federico Nalesso

Förderung

  • University of Padua
  • Università di Padova

Zitieren

APA

Martino, F. K., Fioretti, F., Stefanelli, L. F., Carraro, G., Capuano, M., Scaparrotta, G., & Nalesso, F. (2026). Clinical Impact of RSV Vaccination in Hemodialysis Patients: Real-World Evidence on Hospitalization Risk and the Role of Chronic Lung Disease. Advances in Respiratory Medicine, 94(4), 45. https://doi.org/10.3390/arm94040045

Vancouver

Martino FK, Fioretti F, Stefanelli LF, Carraro G, Capuano M, Scaparrotta G, et al. Clinical Impact of RSV Vaccination in Hemodialysis Patients: Real-World Evidence on Hospitalization Risk and the Role of Chronic Lung Disease. Advances in Respiratory Medicine. 2026;94(4):45. doi:10.3390/arm94040045

BibTeX
@article{Martino2026,
  author = {Martino, Francesca K and Fioretti, Francesca and Stefanelli, Lucia Federica and Carraro, Gianni and Capuano, Miriam and Scaparrotta, Giuseppe and Nalesso, Federico},
  title = {Clinical Impact of RSV Vaccination in Hemodialysis Patients: Real-World Evidence on Hospitalization Risk and the Role of Chronic Lung Disease},
  journal = {Advances in Respiratory Medicine},
  year = {2026},
  volume = {94},
  number = {4},
  pages = {45},
  doi = {10.3390/arm94040045}
}
Kostenlos starten →